Dear Healthcare Professional Letters
Important information on SynchroMed® II implantable drug infusion pump design change
Audiences
Healthcare professional
Product type
Medical devices
4 January 2018
This article has been migrated from an earlier version of the site and may display formatting inconsistencies.
Medtronic International Ltd would like to inform healthcare professionals of a design change to the SynchroMed® II implantable drug infusion pump that reduces the likelihood for non-recoverable motor stall, which can cause loss of therapy. Medtronic recommends the SynchroMed® II infusion system be used according to approved product labelling. All SynchroMed®II infusion pumps are now manufactured with the new design change. To ensure patients have access to uninterrupted therapy, pumps manufactured prior to this latest change will remain available subject to certain requirements and conditions. Once there is sufficient inventory of the pumps with the new design, pumps manufactured prior to this change will no longer be distributed. Please refer to the letter for details.
Only abstracts of the Dear Healthcare Professional Letters (DHCPL) are provided on this website. Details of these letters can be found in the MOH Alert System, which is accessible via the Health Professionals Portal (HPP), a one-stop portal for all healthcare professionals in Singapore. Dentists, medical doctors and pharmacists may access HPP at https://hpp.moh.gov.sg and follow the procedures below to access the MOH Alert system.
Step 1: Select your profession under ‘For Healthcare Professionals’.
Step 2: Click on ‘Useful links’.
Step 3: Click on ‘MOH Alert’ and log in via Singpass.
Step 4: Click on ‘Drug Alerts’ or ‘Med Device Alerts’ to view the DHCPLs.